drugset / Trial / NCT05698459
OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
NaSingle-groupOpen-labelTreatment
Summary
An open-label dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of OH2 injection via transcatheter Intraarterial infusion in patients with advanced hepatocellular carcinoma
Timeline
- Start
- 2023-05-05
- Primary completion
- 2025-08
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OH2 | Other / unclassified | — | Other |